Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The authors support the concept that the time to peak submaximal effect is important information derived from the time course of a drug's effect in pharmacokinetic-pharmacodynamic modeling.
To the Editor:— We congratulate Dr. Minto et al . 1for the introduction of the concept of and have several comments about its tpeakapplication.To conclude, we support the notion that the time to peak submaximal effect is important information to be obtained from the time course of the effect. It is important to stress that the peak effect must be submaximal. Simulation in a pharmacokinetic–pharmacodynamic model, if successful, produces a time course of the drug concentration in the effect compartment such that the peak concentration and the simulated peak effect occur at the time of the observed peak submaximal effect. Optimally, the whole simulated time course of the pharmacologic effect is close to the observed. The time to peak concentration in the effect compartment is a derived but unique function of keoand the parameters in the polyexponential description of the time course of plasma concentrations. The time to peak submaximal effect is an observed value.Medical College of Ohio, Toledo, Ohio. vnigrovic@mco.edu
No takes yet. Share an insight, caveat, or question.
Nigrović et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: